Latest Market News

S&P Global Ratings has assigned TPG Telecom a BBB credit rating with a negative outlook, reflecting uncertainties around its capital reinvestment and debt reduction plans following a major asset sale to Vocus Group.

AKORA Resources has launched a $2.91 million capital raising through a placement and entitlement offer to fund critical development milestones at its Bekisopa Iron Ore Project in Madagascar.

WAM Alternative Assets Limited has announced a 15.4% increase in its fully franked final dividend for FY2025, reflecting robust portfolio gains and a confident outlook under Wilson Asset Management's stewardship.

Altair Minerals has entered a binding agreement to acquire up to 70% of the Greater Oko Project in Guyana, positioning itself as a leading gold explorer in a rapidly emerging district adjacent to major discoveries.

Nutritional Growth Solutions Ltd has voluntarily suspended trading on the ASX pending a capital raising announcement, signaling a pivotal moment for the pediatric nutrition company.

Silver Mines Limited has raised $33 million through a $30 million placement and a $3 million share purchase plan, bolstering its development and exploration ambitions in Australia and the US.

Zoono Group Limited has closed its recent rights issue, raising $785,000 with a significant shortfall remaining. Managing Director Paul Hyslop fully subscribed and may provide further financial support as the company targets growth in Asia and product innovation.

Horseshoe Metals advances its Horseshoe Lights copper-gold project with mining approval secured, site mobilization underway, and new drilling planned to expand resources.

Pure Foods Tasmania has raised $150,000 through a strategic share and option placement, signaling strong investor confidence in its ongoing turnaround strategy.

D3 Energy’s latest re-test of the RBD10 well in South Africa’s ER315 permit shows a remarkable 38% increase in gas flow, underscoring unique reservoir dynamics that could lower development costs.

TMK Energy has forged a strategic alliance with Beijing-based J-Energy to accelerate development planning for its Gurvantes XXXV Coal Seam Gas project in Mongolia, leveraging J-Energy’s technical expertise and Chinese market connections.

Immutep has received encouraging feedback from the FDA on its immunotherapy eftilagimod alfa combined with KEYTRUDA for patients with low PD-L1 expression in head and neck cancer, opening potential accelerated approval pathways.